- What Is It
- Risk Factors
Monoclonal gammopathy of undetermined significance (MGUS) is a precancerous condition that affects plasma cells. A patient with MGUS has an increased risk of developing blood cancer, such as myeloma or lymphoma.
However, the risk is relatively low. About 1% of those with MGUS develop cancer, as suggested in follow-up studies conducted every year on these patients.
What is monoclonal gammopathy?
Monoclonal gammopathy is a condition in which plasma cells produce abnormal proteins that spill over in the blood.
Plasma cells are a type of white blood cell that produce antibodies to fight infections in the bone marrow.
The abnormal protein produced by plasma cells is called M-protein or a paraprotein. It is called monoclonal because even if it is made by several cells, they are identical and produced by one family of cells.
What are the symptoms of monoclonal gammopathy?
Usually, most patients with MGUS may not experience any symptoms at all (benign monoclonal gammopathy).
However, some patients may present with symptoms such as:
What are the risk factors of monoclonal gammopathy?
The exact cause of MGUS is unclear, but experts believe that it may be caused by a combination of genetic changes and environmental factors.
Age is the most significant risk factor of monoclonal gammopathy MGUS. M-protein is found in the blood of about 3% of adults ages 50 and older; 5% of those are 70 and older. Adults 85 and up make up most cases.
Other risk factors include:
How is monoclonal gammopathy diagnosed?
Because monoclonal gammopathy causes few or no symptoms, the condition is usually diagnosed during routine blood and urine tests that show the presence of M-protein. To confirm a diagnosis, a serum electrophoresis test is recommended to confirm the presence of the abnormal M-protein.
Following a diagnosis, the patient may be subjected to a series of tests to determine the status and progression of the disease:
- Bone marrow biopsy: A small sample of bone marrow is aspirated and tested to detect the number of affected plasma cells in the bone marrow.
- 24-hour urine test: Urine is collected during a 24-hour period and checked for the total amount of M-protein.
- Blood tests: Blood tests are done to check for the amount of M-protein in the blood. Functionality tests of major organs, especially the kidneys, may be done as well.
- Radiological imaging: Radiological imaging tests, such as computed tomography, magnetic resonance imaging, positron emission tomography, etc., are done to detect complications such as osteoporosis and cancer development.
What are the treatment options for monoclonal gammopathy?
Most patients with MGUS do not require therapy, although others may require therapy in the future. People with MGUS should undergo blood and urine testing every 6-12 months to see if the disease is progressing.
Although no active therapy is required for MGUS, regular monitoring is advised through clinical assessments and serum protein measurements. To establish a definitive diagnosis of MGUS, the serum protein should be tested after 3 months and then again after 6 months. If the paraprotein has stayed steady, it should be tested every year after that. As there is a chance of developing osteoporosis, medications to improve bone density may be recommended.
MGUS may progress to specific forms of blood cancers in a small percentage of people:
Treatment for such patients depends on the type and stage of cancer. Annual follow-up is recommended to scan for the development of any abnormalities.
Latest MedicineNet News
Daily Health News
Health Solutions From Our Sponsors
Mouhieddine TH, Weeks LD, Ghobrial IM. Monoclonal gammopathy of undetermined significance. Blood. 2019; 133 (23): 2484-2494. https://ashpublications.org/blood/article/133/23/2484/273836/Monoclonal-gammopathy-of-undetermined-significance
Roswell Park. What Is MGUS? - Monoclonal Gammopathy of Undetermined Significance. https://www.roswellpark.org/cancer/multiple-myeloma/about/mgus
Top Is Monoclonal Gammopathy a Cancer Related Articles
AmyloidosisAmyloidosis is a group of diseases resulting from abnormal deposition of certain proteins (amyloids) in various bodily areas. The amyloid proteins may either be deposited in one particular area of the body (localized amyloidosis) or they may be deposited throughout the body (systemic amyloidosis). There are three types of systemic amyloidosis: primary (AL), secondary (AA), and familial (ATTR). Primary amyloidosis is not associated with any other diseases and is considered a disease entity of its own. Secondary amyloidosis occurs as a result of another illness. Familial Mediterranean Fever is a form of familial (inherited) amyloidosis. Amyloidosis treatment involves treating the underlying illness and correcting organ failure.
Blood Cancer TypesTypes of blood cancers include leukemia, lymphomas, multiple myelomas, and others discussed in this slideshow. Symptoms may include fever, night sweats, fatigue, and other symptoms. Blood cancer treatment depends on the type of cancer and other factors. Blood tests for cancer as well as imaging tests and needle biopsy may help diagnose the condition.
Can Lymphoma Be Completely Cured?Lymphomas are considered to be a treatable form of cancer if detected early. The overall 5-year survival rate for non-Hodgkin lymphoma (NHL) is 62%, whereas the 5-year survival rate for Hodgkin lymphoma is 92% if detected early.
How Is Monoclonal Gammopathy Treated?What is monoclonal gammopathy of undetermined significance (MGUS)? Learn about symptoms, risk factors, and treatment.
How Long a Person Can Live With Multiple Myeloma?Since 2000, the percentage of patients living five years after diagnosis has been on the rise. With improved treatment, survival results are likely to be better. According to the American Cancer Society, the median survival rates are 62 months for Stage I, 42 months for Stage II, and 29 months for Stage III.
Is Multiple Myeloma Cancer Curable?There is no cure for multiple myeloma. Treatment for multiple myeloma can only reduce the severity of its symptoms and extend the patient’s survival by a few months or two to three years. The best treatment for multiple myeloma varies from patient to patient and is often a combination of various therapies, including immunomodulators, steroids, chemotherapy drugs, bisphosphonate therapy, blood or platelet transfusions, plasmapheresis (filtering the blood), radiation therapy, surgery, and bone marrow transplant.
Multiple MyelomaMultiple myeloma is a form of cancer that develops in plasma cells, the white blood cells that make antibodies. Symptoms include bone pain, weakness, extreme thirst, nausea, frequent urination, and broken bones. Treatment of multiple myeloma depends upon the staging and symptoms of the disease.
Multiple Myeloma QuizMultiple myeloma is a form of cancer. Take this quiz common signs and symptoms of multiple myeloma and who is at risk.
Multiple Myeloma: Deadly to ChronicMultiple myeloma is cancer of the plasma cells. The plasma cells are a type of white blood cell present in the bone marrow. Plasma cells are part of the immune system and help fight against infections by producing antibodies that recognize and attack microorganisms. In multiple myeloma, cancer cells accumulate in the bone marrow and replace healthy blood cells.
Multiple Myeloma: Types of TreatmentMultiple myeloma is a cancer of the plasma cells. The plasma cells are a type of white blood cell present in the bone marrow. Plasma cells are part of the immune system and help fight against infections by producing antibodies that recognize and attack microorganisms.
Non-Hodgkin's Lymphoma QuizWhat is Non-Hodgkin's Lymphoma? Take this quiz to learn about the causes, symptoms, and treatments for this cancer that begins in your lymphatic system.